Schedule 13D ownership disclosure
Acumen Pharmaceuticals, Inc.
Security class unavailable · CUSIP: 00509G209
Event date: 2023-07-21
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 25.9000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-23-083859
- Form type
- SC 13D
- Filer
- Acumen Pharmaceuticals, Inc.
- CIK
- CIK 1576885
- Filed
- Jul 25, 2023
- Reporting period
- Jul 21, 2023
- Description
- Schedule 13D beneficial ownership